Sangoma Board Approves Sale of Company; $68.4M Goodwill Impairment and Material Weakness Disclosed
SANG is trading near its 52-week low of $3.4 (11% above the low) on elevated volume (5.5× avg).
Summary
Sangoma's Board approved the sale of the company on September 28, 2026, subject to closing conditions. The annual report also discloses a $68.4M goodwill impairment, a material weakness in ICFR, and a 15% revenue decline. Sangoma agreed to be acquired by BRC Group for $204M enterprise value; shareholders get $4.925 cash and 0.04767 BRC shares per share, a 47% premium.
Updated with a Seeking Alpha report · What changed
Updates
· SEC 6-K — The 6-K attaches the definitive arrangement agreement, with termination fee of $5,397,000 and closing expected by early 2027.
· Seeking Alpha — Sangoma agreed to be acquired by BRC Group for $204M enterprise value; shareholders get $4.925 cash and 0.04767 BRC shares per share, a 47% premium.
Key Events · M&A and Partnerships · SANG
-
Updated · · Seeking Alpha
Board Approves Sale to BRC Group
On September 28, 2026, the Board approved the sale of Sangoma, subject to certain closing conditions. Sangoma agreed to be acquired by BRC Group for $204M enterprise value; shareholders get $4.925 cash and 0.04767 BRC shares per share, a 47% premium. This follows the strategic review process announced May 13, 2026.
-
$68.4M Goodwill Impairment
A non-cash goodwill impairment of $68,394 was recognized in fiscal 2026, reducing goodwill from $186.8M to $118.4M. The impairment resulted from a higher discount rate driven by macroeconomic factors.
-
Material Weakness in ICFR
Management identified a material weakness in internal control over financial reporting related to revenue recognition and deferred revenue reconciliation processes during the ERP rollout. Remediation efforts are ongoing.
-
Revenue Declines 15%
Fiscal 2026 revenue was $200.1M, down from $236.7M in fiscal 2025. Net loss was $81.1M ($2.44 per share) compared to a $5.0M loss in the prior year.
Analysis · SANG · Technology
The Board approved the sale of Sangoma on September 28, 2026, subject to closing conditions — a thesis-altering event for shareholders. The same filing reveals a $68.4 million non-cash goodwill impairment, a material weakness in internal controls over revenue recognition, and a 15% revenue decline to $200.1 million. The sale approval follows a strategic review announced May 13, 2026, and represents the culmination of that process. Sangoma agreed to be acquired by BRC Group for $204M enterprise value; shareholders get $4.925 cash and 0.04767 BRC shares per share, a 47% premium. Investors should note the sale is subject to closing conditions and no purchase price or buyer is disclosed in the filing.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 42.2% of the 325 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.39%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SANG was trading at $3.79 on NASDAQ in the Technology sector, with a market capitalization of approximately $119.5M. The 52-week trading range was $3.40 to $6.46. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.